0
Article |

Phenylalanine Embryopathy in Three Siblings: Implications of Maternal Diet Therapy FREE

RONALD P. BACHMAN, MD; EDGAR J. SCHOEN, MD; MARTHA V. BACKSTROM, RN, MSW; ROBIN F. LEE, MS; SUE RODWELL WILLIAMS, PHD, MPH, RD; ELAINA R. JURECKI, MS, RD
Am J Dis Child. 1993;147(1):22-23. doi:10.1001/archpedi.1993.02160250024009.
Text Size: A A A
Published online

Sir.—Levy and Waisbren1,2 have shown that maternal hyperphenylalaninemia during pregnancy causes characteristic embryopathy including mental retardation, microcephaly, low birth weight, congenital heart disease, and typical dysmorphic facies. Although it is believed that phenylalanine embryopathy may be prevented by a low-phenylalanine diet, preferably beginning before conception,3,4 the "safe" maternal serum phenylalanine level has not been established. We observed a woman of normal health and intelligence with previously undiagnosed hyperphenylalaninemia who gave birth to two infants with severe phenylalanine embryopathy, causing mental retardation and microcephaly. Before her third pregnancy, she started a low-phenylalanine diet that resulted in excellent control of serum phenylalanine levels, but the third child has dysmorphic facies and delayed development.

Patient Report.—A 30-year-old woman was seen in May 1987 for prenatal counseling. Hyperphenylalaninemia had been diagnosed in 1985 when, after the birth of her second abnormal infant, she was discovered to have serum phenylalanine levels

REFERENCES

Levy, HL, Waisbren SE.  Effects of untreated maternal phenylketonuria and hyperphenylalaninemia on the fetus . N Engl J Med. 1983;; 309:1269-1274.
Waisbren SE, Levy HL.  Effects of untreated maternal hyperphenylalaninemia on the fetus: further study of families identified by routine cord blood screening . J Pediatr. 1990;; 116:926-929.
Rohr FJ, Doherty LB, Waisbren SE, et al.  New England maternal PKU project: prospective study of untreated and treated pregnancies and their outcomes . J Pediatr. 1987;;110: 391-398.
Rouse B, Lockhart L, Matalon R, et al.  Maternal phenylketonuria pregnancy outcome: a preliminary report of facial dysmorphology and major malformations . J Inherit Metab Dis. 1990;; 13:289-291.
Kirkman HN.  Projections of a rebound in frequency of mental retardation from phenylketonuria . Appl Res Ment Retard . 1982;;3: 319-328.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Levy, HL, Waisbren SE.  Effects of untreated maternal phenylketonuria and hyperphenylalaninemia on the fetus . N Engl J Med. 1983;; 309:1269-1274.
Waisbren SE, Levy HL.  Effects of untreated maternal hyperphenylalaninemia on the fetus: further study of families identified by routine cord blood screening . J Pediatr. 1990;; 116:926-929.
Rohr FJ, Doherty LB, Waisbren SE, et al.  New England maternal PKU project: prospective study of untreated and treated pregnancies and their outcomes . J Pediatr. 1987;;110: 391-398.
Rouse B, Lockhart L, Matalon R, et al.  Maternal phenylketonuria pregnancy outcome: a preliminary report of facial dysmorphology and major malformations . J Inherit Metab Dis. 1990;; 13:289-291.
Kirkman HN.  Projections of a rebound in frequency of mental retardation from phenylketonuria . Appl Res Ment Retard . 1982;;3: 319-328.

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.